Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance.
Daniel D ShapiroJustin R GreggAmy H LimGraciela M Nogueras-GonzálezHaesun ChoiHyunseon C KangIrene A InguilloBrian F ChapinJohn W DavisJohn F WardPublished in: BJU international (2020)
The addition of MRI-targeted biopsies to SB in the confirmatory biopsy setting among men with previously detected prostate cancer resulted in fewer negative confirmatory biopsies and detection of more clinically significant prostate cancer compared to SB alone.